Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03304730 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prognostic Factors in Zygapophyseal Osteoarthritis Infiltration: a Prospective Cohort Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Dec 2026 → Dec 2028
See other at-risk trials from Hospital Israelita Albert Einstein

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2026 to Dec 2028 Show 4 more changesShow less
    • Study completion pushed from Dec 2027 to Dec 2029
    • Eligibility criteria expanded, about 21 words
    • Publications: details revised at 22 of 25 entries
    • Study description expanded, about 3 words
  2. Primary completion date: Dec 2025 to Dec 2026
    • Study completion date: Dec 2026 to Dec 2027
    • Site details revised
    v10
  3. Primary completion date: Dec 2023 to Dec 2025
    • Study completion date: Dec 2024 to Dec 2026
    v9
  4. Primary completion date: Dec 22, 2023 to Dec 2023
    • Study completion date: Dec 22, 2024 to Dec 2024
    • Study description shortened, about 72 words
    v8
  5. Primary completion date: Dec 22, 2020 to Dec 22, 2023
    • Study completion date: Dec 22, 2021 to Dec 22, 2024
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Re-verified, no change to tracked fieldsv6
  2. Eligibility criteria expanded, about 1 wordv5
  3. Eligibility criteria shortened, about 39 wordsv4
  4. Secondary endpoints: details revised at 4 of 4 entriesv3
  5. Primary completion date: Sep 22, 2019 to Dec 22, 2020
    • Study completion date: Sep 22, 2020 to Dec 22, 2021
    • Eligibility criteria expanded, about 143 words
    • Secondary endpoints revised (4)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Magnet Resonance Image findings of facet osteoarthritis and patient characteristics are prognostic factors for improving or worsening the clinical outcome after treatment with facet infiltration.
Trial Details
NCT Number NCT03304730
Lead Sponsor Hospital Israelita Albert Einstein
Conditions
(from sponsor)		 Degenerative Arthropathy of Lumbar Spinal Facet Joint
Related terms Low Back Pain, Osteoarthritis, Spine
Enrollment 147 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov